Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts

Ellen Stelloo, Remi A. Nout, Elisabeth M. Osse, Ina J. Juergenliemk-Schulz, Jan J. Jobsen, Ludy Lutgens, Elzbieta M. van der Steen-Banasik, Hans W. Nijman, Hein Putter, Tjalling Bosse, Carien L. Creutzberg, Vincent T. H. B. M. Smit

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)4215-4224
JournalClinical Cancer Research
Volume22
Issue number16
DOIs
Publication statusPublished - 15 Aug 2016

Cite this

Stelloo, E., Nout, R. A., Osse, E. M., Juergenliemk-Schulz, I. J., Jobsen, J. J., Lutgens, L., van der Steen-Banasik, E. M., Nijman, H. W., Putter, H., Bosse, T., Creutzberg, C. L., & Smit, V. T. H. B. M. (2016). Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts. Clinical Cancer Research, 22(16), 4215-4224. https://doi.org/10.1158/1078-0432.CCR-15-2878